https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/accounts-payable https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/accretion-amortization-of-discounts-and-premiums-investments https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/accrued-liabilities-current https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/accrued-professional-fees-current-and-noncurrent https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/accumulated-depreciation https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/activist-13d-13g-form-sc-13d https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/activist-13d-13g-form-sc-13g https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/amended-reports-10-k https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/amended-reports-10-q https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/amortization-of-debt-discount-premium https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/aoci https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/asset-impairment-charges https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/available-for-sale-accumulated-gross-unrealized-gain-before-tax https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/available-for-sale-accumulated-gross-unrealized-loss-before-tax https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/available-for-sale-debt-accumulated-gross-unrealized-gain-before-tax https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/available-for-sale-debt-accumulated-gross-unrealized-loss-before-tax https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/available-for-sale-debt-amortized-cost-basis https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/available-for-sale-debt-current https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/available-for-sale-debt-gross-unrealized-loss https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/available-for-sale-debt-maturities-amortized-cost https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/available-for-sale-debt-noncurrent https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/available-for-sale-debt-realized-gain-loss https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/available-for-sale-debt-securities https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/available-for-sale-debt-unrealized-loss-position https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/available-for-sale-debt-unrealized-loss-position-12-months-or-longer-number-of-positions https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/available-for-sale-debt-unrealized-loss-position-less-than-12-months https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/available-for-sale-debt-unrealized-loss-position-less-than-12-months-number-of-positions https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/available-for-sale-debt-unrealized-loss-position-loss https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/available-for-sale-debt-unrealized-loss-position-number-of-positions https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/available-for-sale-fair-value-disclosure https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/available-for-sale-gross-realized-gain-loss-net https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/available-for-sale-gross-unrealized-gain https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/available-for-sale-gross-unrealized-losses https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/available-for-sale-in-unrealized-loss-positions-qualitative-disclosure-number-of-positions-greater-than-or-equal-to-one-year https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/available-for-sale-in-unrealized-loss-positions-qualitative-disclosure-number-of-positions-less-than-one-year https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/available-for-sale-securities https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/available-for-sale-unrealized-loss-position-less-than-twelve-months-fair-value https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/banking-fees-and-commissions https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/basic-shares https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/buybacks-shares-repurchased-value https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/capital-expenditures https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/capital-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/cash-and-cash-equivalents-change https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/cash-and-cash-equivalents-fair-value-disclosure https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/cash-and-equivalents https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/cash-flow-breakdown https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/class-of-warrant-or-right-number-of-securities-called-by-warrants-or-rights https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/clinical-trials https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/common-stock-value https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/comprehensive-income https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/concept-stock-issued-tag-2 https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/construction-and-development-costs https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/contracts-revenue https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/convertible-debt-current https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/current-assets https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/current-liabilities https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/debt-interest-rate-effective-percentage https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/debt-interest-rate-stated-percentage https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/deferred-rent-credit-current https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/deferred-rent-credit-noncurrent https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/deferred-revenue https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/deferred-revenue-noncurrent https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/deferred-revenue-revenue-recognized https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/deferred-tax-assets-deferred-income https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/deferred-tax-assets-goodwill-and-intangible-assets https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/deferred-tax-assets-tax-credit-carryforwards https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-accrued-liabilities https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/deferred-tax-liabilities-other https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/defined-contribution-plan-employer-discretionary-contribution-amount https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/defined-contribution-plan-employer-matching-contribution-percent https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/defined-contribution-plan-employer-matching-contribution-percent-of-match https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/depreciation https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/diluted-shares https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/dilutive-shares https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/due-from-related-parties-current https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/due-to-related-parties-current https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/due-to-related-parties-noncurrent https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/eps https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/eps-basic https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/extinguishment-of-debt-amount https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/fair-value-assets-level-1-to-level-2-transfers-amount https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/fair-value-liabilities-level-1-to-level-2-transfers-amount https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/financing-cash-flow https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/form-d-stocks https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/gain-loss-on-termination-of-lease https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/general-and-administrative-expense https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/impairment-of-investments https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/impairment-of-long-lived-assets-held-for-use https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/income-tax https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/income-tax-examination-penalties-and-interest-accrued https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/income-tax-examination-penalties-and-interest-expense https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/income-taxes-paid https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/increase-decrease-due-from-other-related-parties https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/increase-decrease-in-deferred-liabilities https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/increase-decrease-in-notes-payable-current https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/increase-decrease-in-operating-lease-liability https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/increase-decrease-in-receivables https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/increase-decrease-in-unbilled-receivables https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/incremental-common-shares-attributable-to-share-based-payment-arrangements https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/insider-transactions-other https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/insider-transactions-stock-units https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/insider-transactions-warrants https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/insider-transactions-warrants/purchases https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/interest-expense https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/interest-expense-on-debt https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/interest-expense-other https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/interest-expense-related-party https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/interest-paid https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/interest-paid-net https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/investing-cash-flow https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/investment-income-interest https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/investment-income-nonoperating https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/investment-warrants-exercise-price https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/issuance-of-stock-and-warrants-for-services-or-claims https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/lease-and-rental-expense https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/lease-incentive-payable-current-and-noncurrent https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/leasehold-improvements-gross https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/letters-of-credit-outstanding-amount https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/line-of-credit-facility-commitment-fee-amount https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/line-of-credit-facility-maximum-borrowing-capacity https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/line-of-credit-facility-unused-capacity-commitment-fee-percentage https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/long-term-debt-fair-value https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/marketable-securities-unrealized-gain-loss https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/maturities-of-available-for-sale-securities https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/net-cash-from-financing-activities https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/net-cash-from-investing-activities https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/net-change-in-cash https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/net-income https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/net-income-loss-available-to-common-stockholders-diluted https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/notes-reduction https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/number-of-operating-segments https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/oci-reclassification-adjustment-from-aoci-for-sale-of-securities-net-of-tax https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/oci-unrealized-holding-gain-loss-on-securities-arising-net-of-tax https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/operating-cash-flow https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/operating-expenses https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/operating-income https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/operating-lease-assets https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/operating-lease-cost https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/operating-lease-liability https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/operating-lease-liability-current https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/operating-lease-payments https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/operating-lease-payments-due https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/operating-lease-payments-due-2 https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/operating-lease-payments-due-after-year-five https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/operating-lease-payments-due-future-minimum-sublease-rentals https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/operating-lease-payments-due-year-five https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/operating-leases-future-minimum-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/operating-leases-rent-expense-sublease-rentals https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/operating-loss-carryforwards https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/origination-of-notes-receivable-from-related-parties https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/other-assets-miscellaneous-noncurrent https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/other-current-assets https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/other-income https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/other-noncash-expense https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/other-noncash-income-expense https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/other-noncurrent-assets https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/other-noncurrent-liabilities https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/other-nonoperating-expense https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/other-nonoperating-income https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/other-prepaid-expense-current https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/other-than-temporary-impairment-loss-available-for-sale-debt-recognized-in-earnings https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/other-than-temporary-impairment-losses-investments-portion-recognized-in-earnings-net-available-for-sale-securities https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/paid-in-capital-share-based-compensation-restricted-stock-units-requisite-service-period-recognition https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/paid-in-capital-share-based-compensation-stock-options-requisite-service-period-recognition https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/paid-in-kind-interest https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/patents-active https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/patents-expired https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/patents-pending https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/patents-rejected https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/payments-for-restructuring https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/payments-of-debt-issuance-costs https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/payments-to-acquire-available-for-sale-debt https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/preferred-shares-facts https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/preferred-stock-value https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/prepaid-expense-current https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/prepaid-expense-noncurrent https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/prepaid-rent https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/proceeds-from-issuance-of-shares-under-incentive-and-share-based-compensation-plans https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/proceeds-from-issuance-of-shares-under-incentive-and-share-based-compensation-plans-including-stock-options https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/proceeds-from-payments-for-other-financing-activities https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/proceeds-from-related-party-debt https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/proceeds-from-repayments-of-notes-payable https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/proceeds-from-repayments-of-restricted-cash-financing-activities https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/proceeds-from-sale-of-available-for-sale-debt https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/proceeds-from-sale-of-available-for-sale-securities https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/proceeds-from-sale-of-productive-assets https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/proceeds-from-stock-plans https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/property-plant-and-equipment-disposals https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/property-plant-and-equipment-gross-change https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/property-plant-equipment https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/public-float https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/realized-gains-on-securities https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/receivables-net-current https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/repayments-of-long-term-capital-lease-obligations https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/repayments-of-notes-payable https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/research-and-development https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/restricted-cash https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/restricted-cash-and-cash-equivalents https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/restricted-cash-and-cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/restricted-cash-and-cash-equivalents-noncurrent https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/restricted-cash-current https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/restructuring-and-related-cost-expected-cost-remaining https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/restructuring-and-related-cost-incurred-cost https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/restructuring-and-related-cost-number-of-positions-eliminated https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/restructuring-and-related-cost-number-of-positions-eliminated-period-percent https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/restructuring-reserve https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/restructuring-reserve-current https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/restructuring-reserve-settled-without-cash https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/retained-earnings https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/revenue https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/revenue-from-contract-with-customer-including-assessed-tax https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/right-of-use-asset-obtained-in-exchange-for-operating-lease-liability https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/royalty-expense https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/sale-of-stock-consideration-received-on-transaction https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/sale-of-stock-number-of-shares-issued-in-transaction https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/sale-of-stock-price-per-share https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/sec-comment-letters-corresp https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/sec-comment-letters-upload https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/sec-filings-10-k https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/sec-filings-10-k405 https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/sec-filings-10-q https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/sec-filings-25-nse https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/sec-filings-425 https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/sec-filings-8-a12g https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/sec-filings-8-k https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/sec-filings-ars https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/sec-filings-ct-order https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/sec-filings-def-14a https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/sec-filings-defa14a https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/sec-filings-defm14a https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/sec-filings-pre-14a https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/sec-filings-regdex https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/sec-filings-s-4 https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/secondary-offerings-form-424a https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/secondary-offerings-form-424b3 https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/secondary-offerings-form-424b4 https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/secondary-offerings-form-424b5 https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/secondary-offerings-form-effect https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/secondary-offerings-form-fwp https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/secondary-offerings-form-s-1 https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/secondary-offerings-form-s-3 https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/secondary-offerings-form-s-3asr https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/secondary-offerings-form-s-3mef https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/secondary-offerings-form-s-8 https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/share-based-goods-and-nonemployee-services-transaction-expense https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/share-based-goods-and-nonemployee-services-transaction-valuation-method-expected-volatility-rate https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/shareholders-equity https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/shares-authorized https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/shares-issued https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/stock-award-options-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/stock-award-plan-modification-incremental-compensation-cost https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/stock-award-rsu-vested-in-period-total-fair-value https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/stock-based-compensation https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/stock-compensation-cash-received-from-exercise-of-stock-options https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/stock-compensation-tax-benefit-from-compensation-expense https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/stock-compensation-unrecognized-cost-stock-options https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/stock-issued-shares-issued-value-employee-benefit-plan https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/stock-issued-shares-issued-value-espp https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/stock-issued-shares-issued-value-issued-for-services https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/stock-issued-shares-issued-value-other https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/stock-issued-shares-issued-value-restricted-stock-award-net-of-forfeitures https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/stock-options-exercisable-number https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/stock-options-expirations-in-period https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/stock-options-grants-in-period https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/stock-options-vested-and-expected-to-vest-outstanding-aggregate-intrinsic-value https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/stock-options-vested-and-expected-to-vest-outstanding-average-exercise-price https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/stock-options-vested-and-expected-to-vest-outstanding-number https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/stockholders-equity-other https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/supplies https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/tax-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/tax-reconciliation-other-adjustments https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/tax-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/tax-reconciliation-tax-credits https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/total-assets https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/total-liabilities https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/undistributed-earnings-loss-allocated-to-participating-securities-basic https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/undistributed-earnings-loss-allocated-to-participating-securities-diluted https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/utb-reduction-from-statute-lapse https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/value-added-tax-receivable-current https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/value-added-tax-receivable-noncurrent https://stock.noler.com/us/stock/infinity-pharmaceuticals-inc/weighted-average-number-of-share-outstanding-basic-and-diluted